EyePoint, Inc. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
EyePoint, Inc. (EYPT) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $23.25 million as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-03-05
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $23.25M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $17.72M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $11.72M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $9.46M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
|---|---|
| 2025-12-31 | $23.25M 10-K · filed 2026-03-05 |
| 2024-12-31 | $17.72M 10-K · filed 2026-03-05 |
| 2023-12-31 | $11.72M 10-K · filed 2025-03-06 |
| 2022-12-31 | $9.46M 10-K · filed 2024-03-08 |
| 2021-12-31 | $7.82M 10-K · filed 2023-03-10 |
| 2020-12-31 | $6.85M 10-K · filed 2022-03-14 |
| 2019-12-31 | $5.80M 10-K · filed 2021-03-12 |
| 2018-12-31 | $4.79M 10-K · filed 2020-03-16 |
| 2018-06-30 | $4.24M 10-KT · filed 2019-03-18 |
| 2017-06-30 | $5.11M 10-KT · filed 2019-03-18 |
| 2016-06-30 | $4.11M 10-K · filed 2017-09-13 |
| 2015-06-30 | $3.43M 10-K · filed 2016-09-13 |
| 2014-06-30 | $3.08M 10-K · filed 2015-09-10 |
| 2013-06-30 | $2.59M 10-K · filed 2014-09-11 |
| 2012-06-30 | $2.12M 10-K · filed 2013-09-27 |
| 2011-06-30 | $1.61M 10-K · filed 2012-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |